Intractable pneumococcal meningoencephalitis associated with a TNF-α antagonist

J Neurol Sci. 2014 Sep 15;344(1-2):215-8. doi: 10.1016/j.jns.2014.05.038. Epub 2014 May 27.

Abstract

A 34-year-old man was treated with a TNF-α antagonist for ankylosing spondylitis, and this subsequently developed a CNS infection. Magnetic resonance imaging showed diffuse subcortical white matter lesions. Streptococcus pneumoniae was cultured from the cerebrospinal fluid and blood. The patient died of multifocal widespread brain damage and subarachnoid hemorrhage, despite intensive antibacterial medication. Pneumococcal meningoencephalitis can occur in association with TNF-α antagonists. Clinicians should be aware of both the risk of fatal bacterial meningoencephalitis associated with TNF-α antagonists and the possibility of an unusual presentation of bacterial meningitis.

Keywords: Bacterial meningitis; Infliximab; Meningoencephalitis; Streptococcus pneumoniae; TNF-α antagonist; White matter.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / therapeutic use
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Dexamethasone / therapeutic use
  • Diffusion Magnetic Resonance Imaging
  • Humans
  • Male
  • Meningoencephalitis / blood
  • Meningoencephalitis / cerebrospinal fluid
  • Meningoencephalitis / etiology*
  • Pneumococcal Infections / blood
  • Pneumococcal Infections / cerebrospinal fluid
  • Pneumococcal Infections / complications*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • Acyclovir